𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Immunosuppression in HCV-positive liver transplant recipients: Pandora's box?

✍ Scribed by Olivier Boillot; Jérôme Dumortier

Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
65 KB
Volume
13
Category
Article
ISSN
1527-6465

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Corticosteroid-free immunosuppression wi
Corticosteroid-free immunosuppression with daclizumab in HCV+ liver transplant recipients: 1-year interim results of the HCV-3 study
✍ Goran B.G. Klintmalm; W. Kenneth Washburn; Steven M. Rudich; Thomas G. Heffron; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 246 KB

This work is a 1-yr interim analysis of a prospective, randomized, multicenter trial evaluating the effect of corticosteroid-free immunosuppression on hepatitis C virus-positive (HCV ϩ ) liver transplant recipients following liver transplantation (LT). Patients received tacrolimus and corticosteroid

Acute rejection in HCV-infected liver tr
Acute rejection in HCV-infected liver transplant recipients: The great conundrum
✍ James R. Burton Jr.; Hugo R. Rosen 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB 👁 1 views

1. In hepatitis C virus (HCV)-infected patients, treatment of acute rejection is associated with worse outcomes (increased risk of allograft cirrhosis and mortality). 2. Whether patients with HCV are at higher risk for rejection remains controversial. 3. The mechanisms mediating acute rejection and

Alemtuzumab induction in non-hepatitis C
Alemtuzumab induction in non-hepatitis C positive liver transplant recipients
✍ Josh Levitsky; Kavitha Thudi; Michael G. Ison; Edward Wang; Michael Abecassis 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 220 KB 👁 1 views

Limited data exist for the use of alemtuzumab (AL) induction in liver transplantation (LT) recipients. We compared the outcomes of hepatitis C virus-negative LT recipients who received AL induction followed by tacrolimus and mycophenolate mofetil without steroids to cohort who received no AL inducti

Effect of calcineurin inhibitors on surv
Effect of calcineurin inhibitors on survival and histologic disease severity in HCV-infected liver transplant recipients
✍ Marina Berenguer; Victoria Aguilera; Martín Prieto; Fernando San Juan; José M. R 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB 👁 1 views

The severity of recurrent hepatitis C virus (HCV) is likely related to several factors. Controversial results have been reported regarding the effect of specific calcineurin-inhibitors. The aim of this research was to determine whether there are differences on posttransplantation outcome in HCV-infe

Occurrence of gammopathies and lymphopro
Occurrence of gammopathies and lymphoproliferative disorders in liver transplant recipients randomized to tacrolimus (FK506)- or cyclosporine-based immunosuppression
✍ Pham, Hung ;Lemoine, Antoinette ;Salvucci, Marina ;Azoulay, Daniel ;Frenoy, Nico 📂 Article 📅 1998 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 110 KB

Lymphoproliferative disorders (LPDs) are a serious side effect of immunosuppression after liver transplantation, and the introduction on the market of a new immunosuppressive drug has been associated with an increased risk of these disorders. To compare the effect of cyclosporine A (CSA) and FK506 i